Last reviewed · How we verify
Continuous ketorolac
At a glance
| Generic name | Continuous ketorolac |
|---|---|
| Sponsor | Phoenix Children's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery (PHASE4)
- Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy (PHASE3)
- Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid (PHASE2)
- Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection (PHASE3)
- Autonomic Control of the Circulation and VDR (EARLY_PHASE1)
- The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery (PHASE2)
- Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive Mammoplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Continuous ketorolac CI brief — competitive landscape report
- Continuous ketorolac updates RSS · CI watch RSS
- Phoenix Children's Hospital portfolio CI